STOCK TITAN

Silk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Silk Road Medical, Inc. (NASDAQ: SILK) announced its participation in the 41st Annual J.P. Morgan Healthcare Conference. Management will present on January 10, 2023, at 4:30 p.m. PT. Interested parties can access a live and archived webcast via the company's website.

Based in Sunnyvale, California, Silk Road Medical focuses on reducing stroke risks through its innovative TransCarotid Artery Revascularization (TCAR) procedure, which treats carotid artery blockages with a minimally invasive approach.

Positive
  • None.
Negative
  • None.

SUNNYVALE, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.

Silk Road Medical’s management is scheduled to present on Tuesday, January 10, 2023 at 4:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The Company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com


FAQ

When is Silk Road Medical presenting at the J.P. Morgan Healthcare Conference?

Silk Road Medical is scheduled to present on January 10, 2023, at 4:30 p.m. Pacific Time.

How can I access Silk Road Medical's presentation?

You can access the live and archived webcast of Silk Road Medical's presentation on their Investors section of their website.

What is the focus of Silk Road Medical?

Silk Road Medical focuses on reducing the risk of stroke through innovative medical devices and procedures.

What is TCAR and how does it relate to Silk Road Medical?

TransCarotid Artery Revascularization (TCAR) is a procedure pioneered by Silk Road Medical to treat carotid artery disease and reduce stroke risk.

Where is Silk Road Medical located?

Silk Road Medical's headquarters are located in Sunnyvale, California, with additional facilities in Plymouth, Minnesota.

Silk Road Medical, Inc.

NASDAQ:SILK

SILK Rankings

SILK Latest News

SILK Stock Data

1.12B
38.94M
4.15%
97.46%
7.75%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SUNNYVALE